4 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 1 | Unknown 1 |
Follow Coronavirus: new trials by email Literature Review of Coronavirus trials Research Report on Coronavirus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial Angiotensin 1-7, Placebos - Coronavirus, Respiratory Failure | Phase 2 / Phase 3 | Unknown | Erasme University Hospital | 60 | 2021-12-30 | 2021-08-02 |
| Tocilizumab in Coronavirus-19 Positive Patients Tocilizumab - Covid19, COVID-19 | Phase 3 | Unknown | University of Calgary | 30 | 2020-07-30 | 2020-07-22 |
| A Study of a Candidate COVID-19 Vaccine (COV003) ChAdOx1 nCoV-19 single dose + paracetamol, MenACWY single dose + paracetamol, ChAdOx1 nCoV-19 two dose + paracetamol - Coronavirus | Phase 3 | Unknown | University of Oxford | 10300 | 2020-06-02 | 2020-11-27 |
| Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 Darunavir and Cobicistat - Pneumonia, Pneumocystis, Coronavirus | Phase 3 | Unknown | Shanghai Public Health Clinical Center | 30 | 2020-01-30 | 2020-04-13 |
Coronavirus Infections (4) · COVID-19 (3) · Inflammation (1) · Pneumonia (1) · Pneumonia, Pneumocystis (1) · Respiratory Insufficiency (1)
Coronaviridae Infections (4) · Infections (4) · Nidovirales Infections (4) · RNA Virus Infections (4) · Respiratory Tract Diseases (4) · Virus Diseases (4) · Lung Diseases (3) · Pneumonia, Viral (3) · Respiratory Tract Infections (3) · Pneumonia (2) · Bacterial Infections and Mycoses (1) · Lung Diseases, Fungal (1) · Mycoses (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Acetaminophen (1) · ChAdOx1 nCoV-19 (1) · MenACWY (1) · angiotensin I (1-7) (1) · cobicistat mixture with darunavir (1) · tocilizumab (1)
Erasme University Hospital (1) · Shanghai Public Health Clinical Center (1) · University of Calgary (1) · University of Oxford (1)
Brazil (1) · China (1)
Andrew Pollard, Prof (1) · Filippo Annoni, MD (1) · Robson AS Santos, MD,PhD (1) · Susanne Benseler, MD PhD (1)